TheraCal
TheraCal is a pharmaceutical drug with 6 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 3 completed trials
Phase Distribution
Phase Distribution
1
Early Stage
1
Mid Stage
1
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
3 of 3 finished
0.0%
0 ended early
0
trials recruiting
6
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Comparison of Hyaluronic Acid, TheraCal, and Mineral Trioxide Aggregate as Pulpotomy Agents in Primary Molars
Evaluation of Conservative Management of Teeth With Deep Cavitated Carious Lesions
Partial Versus Complete Pulpotomy Using Three Different Materials in Primary Molars: a Clinical Study
Experimental Research on Deep Carious Lesion Treatment of Molars
Antibacterial Effect of Light-activated Calcium Silicate Versus Light-activated Calcium Hydroxide
Clinical Trials (6)
Comparison of Hyaluronic Acid, TheraCal, and Mineral Trioxide Aggregate as Pulpotomy Agents in Primary Molars
Evaluation of Conservative Management of Teeth With Deep Cavitated Carious Lesions
Partial Versus Complete Pulpotomy Using Three Different Materials in Primary Molars: a Clinical Study
Experimental Research on Deep Carious Lesion Treatment of Molars
Antibacterial Effect of Light-activated Calcium Silicate Versus Light-activated Calcium Hydroxide
Effect of Pulpotomy Using TheraCal Versus MTA on Survival Rate of Cariously-Exposed Vital Permanent Molars
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6